JAJuliana Peçanha Antonio

Juliana Peçanha Antonio

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Juliana Peçanha Antonio has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A diet protocol for patients on non-invasive ventilation admitted to a healthcare unit in a tertiary referral center in southern Brazil

    by Juliana Peçanha Antonio, Carolina Ribeiro Anele, Renata Schwartz, Michelle Nunes Silveira, Thais Ortiz Hammes, Mariana Rangel Ribeiro Falcetta, Ana Maria Keller Jochims, Valesca Dall'ALba, Vera Lúcia Bosa

    Introduction: The COVID-19 pandemic posed unprecedented challenges and threats to patients and healthcare systems worldwide. The high risk of malnutrition highlighted the importance of early nutrition intervention. Objective: To develop a personalized dietary protocol for patients requiring non-invasive ventilation (NIV). Methods: This was a descriptive observational study included adult NIV patients admitted to a tertiary referral center in southern Brazil between March and August 2021. Patients received a dietary protocol consisting of a fractionated, liquidized and pureed diet, supplemented with isolated whey protein. The protocol provided 2,000 kcal/day and 90 g of protein/day. Food intake was continuous monitored using a visual intake scale. The study was approved by the hospital’s ethics committee. Results: A total of 176 patients were evaluated, most male (57%), with a mean age of 56 ± 15 years. The median onset of respiratory symptoms was 9 days. According to the NRS-2002, 83% of the patients were classified as being at risk of malnutrition. Upon admission, 86% required oxygen support, and 94% were exclusively fedorally, with 50% receiving the prescribed diet protocol. Patients on NIV consumed more than half of the prescribed diet and were able to progress to a regular consistency diet by discharge. Conclusion: A fractionated, modified-consistency diet that is easy to chew appears to be a feasible alternative to nasoenteric tube feeding for patients on NIV. In this context, nutritional therapy should be considered a fundamental component of care for these patients in all healthcare settings.

  • Open Access

    Seven versus 14 days of antimicrobial therapy for severe multidrug-resistant Gram-negative bacterial infections in intensive care unit patients (OPTIMISE): a randomised, open-label, non-inferiority clinical trial

    by Beatriz Arns, Andre C. Kalil, Guilherme G. L. Sorio, Emerson Boschi, Ana Carolina Peçanha Antonio, Juliana Peçanha Antonio, Daniella Cunha Birriel, Daniel Haase Lanziotti, Frederico da Cunha Abbott, Glecia Carla Rocha, et al.

    Shorter courses of antimicrobial therapy have been shown to be non-inferior to longer durations for the management of several infections. However, data on critically ill patients with severe infections by multidrug-resistant Gram-negative bacteria (MDR-GNB) are scarce. In the duratiOn of theraPy in severe infecTIons by MultIdrug-reSistant gram-nEgative bacteria (OPTIMISE) trial, we assessed the non-inferiority of 7-day versus 14-day antimicrobial therapy for patients with intensive care unit (ICU)-acquired severe infections by MDR-GNB. This was a randomised multicenter, open-label, parallel controlled, non-inferiority trial. Adult patients with severe infections by MDR-GNB initiated ≥ 48 h of ICU admission were eligible if they were hemodynamically stable and without fever > 48 h on the 7th day of appropriate antimicrobial therapy. Patients were 1:1 randomised to discontinue antimicrobial therapy on the 7th (± 1) day or to continue for a total of 14 (± 1) days. The primary outcome was clinical failure, defined as death or relapse of infection within 28 days of randomisation. An upper edge of the two-tailed 95% confidence interval (CI) of the delta between the clinical failure rate in the 7- and the 14-day lower than 10% in both intention-to-treat (ITT) and per protocol (PP) analyses was set as the non-inferiority criteria. A total of 106 patients composed the ITT population: 59 and 47 allocated to 7- and 14-day groups, respectively. The PP population included 75 patients: 47 and 28 in the 7- and 14-day groups, respectively. Clinical failure occurred in 42.4% and 44.7% of the ITT population in 7- and 14-day groups, respectively, (risk difference (RD) − 2.3, 95%CI − 21.3 to 16.7), and in 46.8% and 50.0% of the PP population in 7- and 14-day groups, respectively (RD − 3.2, 95%CI − 26.6 to 20.2). Most infections were of the respiratory tract (73/68.9%) and caused by carbapenem-resistant Enterobacterales (42/39.6%). The study was interrupted before reaching planned sample size due to low recruitment rate. The OPTIMISE trial could not determine the non-inferiority of 7-day compared to 14-day therapy for severe infections caused by MDR-GNB due to early termination related to the low recruitment rate. Trial registration: NCT05210387 on January 13, 2022.


  • Open Access

    Palliative extubation experience in a community hospital in southern Brazil

    by Ana Carolina Peçanha Antonio, Juliana Peçanha Antonio

    Sustaining invasive mechanical ventilation may inappropriately prolong the dying process and perpetuate states worse than death in end-of-life care. Even though withdrawing the ventilator in this circumstance is a well-established practice worldwide1 1 Efstathiou N, Vanderspank-Wright B, Vandyk A, Al-Janabi M, Daham Z, Sarti A, et al. Terminal withdrawal of mechanical ventilation in adult intensive care units: a systematic review and narrative synthesis of perceptions, experiences and practices. Palliat Med. 2020;34(9):1140-64. https://doi.org/10.1177/0269216320935002 https://doi.org/10.1177/0269216320935002... , Brazilian physicians are far more likely to withhold than withdraw life-sustaining treatments2 2 Yaguchi A, Truog RD, Curtis JR, Luce JM, Levy MM, Mélot C, et al. International differences in end-of-life attitudes in the intensive care unit: results of a survey. Arch Intern Med. 2005;165(17):1970-5. https://doi.org/10.1001/archinte.165.17.1970 https://doi.org/10.1001/archinte.165.17.... –5 5 Furtado RA, Tonial CT, Costa CAD, Andrades GRH, Crestani F, Bruno F, et al. End-of-life practices in patients admitted to pediatric intensive care units in Brazil: a retrospective study. J Pediatr (Rio J). 2021;97(5):525-30. https://doi.org/10.1016/j.jped.2020.10.017 https://doi.org/10.1016/j.jped.2020.10.0... .


  • Association of Eating Patterns and Diabetic Kidney Disease in Type 2 Diabetes: A Cross-Sectional Study

    by Cíntia Corte Real Rodrigues, Bárbara Pelicioli Riboldi, Ticiana da Costa Rodrigues, Roberta Aguiar Sarmento, Juliana Peçanha Antonio, Jussara Carnevale de Almeida


  • Open Access

    Adiposity markers and risk of coronary heart disease in patients with type 2 diabetes mellitus

    by Simone F Tonding, Flávia M Silva, Juliana P Antonio, Mirela J Azevedo, Luis Henrique S Canani, Jussara C Almeida

    This cross-sectional study aimed to evaluating the association between body adiposity markers and high-risk of coronary heart disease (CHD) in patients with type 2 diabetes. Recent adiposity markers [waist-to-height ratio, conicity index (C-index) and body adiposity index] and traditional markers [BMI, waist circumference and waist-to-hip ratio (WHR)] were measured. The 10-year risk of fatal CHD was estimated according to UKPDS risk engine scores. Patients were divided into high (CHD risk ≥20%; n = 99) or low-moderate (CHD risk 20% (OR = 1.69; 95% CI 1.03-2.78; P = 0.039) after adjusting for confounders (sedentary lifestyle, diabetic nephropathy, serum creatinine, and diabetes duration). The association between WHR and CHD risk did not hold in this sample. The C-index was the body adiposity marker best associated with high risk of fatal CHD in these patients with type 2 diabetes.